Loading
CI
Cempra, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Vatera Healthcare Partners LLC, was filed 31 May 2018.
Cempra, Inc.: what insiders have been doing
Every trade that managers of Cempra, Inc. disclose to SEC (Form 4) is tracked on this page. The past year has been quiet: not a single insider filing for Cempra, Inc. The previous disclosure was published on 2 July 2019.
Since 2016, the database holds 12 purchases and 7 sales by insiders of the company.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
29
Thresholds
n/a
Buy Volume
€109M
12 ops. · all time
Sell Volume
€4M
7 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2018FY ended December 2018 · cache
Income statement
Revenue86M
Net income-140.1M-163.0% margin
Last declaration on 2 July 2019
Declarations29 total
13,000 shares@ US$5.57100.0% of flowMelinta Common StockSEC:0001461993-19-000037:0
50,000 shares0Melinta Common StockSEC:0001461993-19-000035:0
7,500,000 shares@ US$5.0029.8% of flowCommon StockSEC:0000899243-18-014562:0
Canonical exit: 27 Aug 2018 (T+90)
7,878,500 shares@ US$5.0031.3% of flowCommon StockSEC:0000899243-18-014562:1
Canonical exit: 27 Aug 2018 (T+90)
10,000 shares@ US$5.00100.0% of flowCommon StockSEC:0000899243-18-014568:0
Canonical exit: 27 Aug 2018 (T+90)
4,000 shares@ US$5.00100.0% of flowCommon StockSEC:0000899243-18-014564:0
Canonical exit: 27 Aug 2018 (T+90)
50,000 shares@ US$5.00100.0% of flowCommon StockSEC:0000899243-18-014563:0
Canonical exit: 27 Aug 2018 (T+90)
4,000 shares@ US$5.00100.0% of flowCommon StockSEC:0000899243-18-014561:0
Canonical exit: 27 Aug 2018 (T+90)
40,000 shares@ US$5.00100.0% of flowCommon StockSEC:0000899243-18-014565:0
Canonical exit: 27 Aug 2018 (T+90)
5,000 shares@ US$6.0964.9% of flowCommon StockSEC:0000899243-18-014450:0
Canonical exit: 23 Aug 2018 (T+90)
1,777,778 shares@ US$13.5018.3% of flowCommon StockSEC:0000899243-18-000837:0
Canonical exit: 5 Apr 2018 (T+90)
2,000,000 shares@ US$13.5020.5% of flowCommon StockSEC:0000899243-18-000837:1
Canonical exit: 5 Apr 2018 (T+90)
50,100 shares@ US$3.534.3% of flowCommon StockSEC:0000950142-17-000550:0
99,900 shares@ US$3.578.7% of flowCommon StockSEC:0000950142-17-000550:1
105,460 shares@ US$3.408.7% of flowCommon StockSEC:0000950142-17-000120:0
500,000 shares@ US$3.2039.2% of flowCommon StockSEC:0000950142-17-000081:0
437,600 shares@ US$3.6438.6% of flowCommon StockSEC:0000950142-17-000081:1
5,000 shares@ US$2.9435.1% of flowCommon StockSEC:0001209191-17-000499:0
Canonical exit: 3 Apr 2017 (T+90)
15,000 shares@ US$13.10Common StockSEC:0001209191-16-146485:0
1,000,000 shares0Common StockSEC:0001192482-16-000727:0
2,488 shares0Common StockSEC:0001192482-16-000727:1
999,955 shares0Common StockSEC:0000950142-16-003306:0
594,258 shares0Common StockSEC:0001209191-16-105545:0
405,742 shares0Common StockSEC:0001209191-16-105545:1
15,790 shares@ US$6.0040.0% of flowCommon StockSEC:0001209191-16-105545:2
25 of 29 declarations
About Cempra, Inc.
Cempra, Inc. is a biopharmaceutical company focused on developing treatments for bacterial infections. It is listed on NASDAQ under the symbol CEMP.
